LPPS

AmbioPharm, a Global Peptide CDMO

Retrieved on: 
Wednesday, July 26, 2023
Manufacturing, Other Manufacturing, Health, Pharmaceutical, Clinical Trials, GMP, QMS, Clinical quality management system, Hydrogenation, API, Toxicology, Research, History, Quality, Quality management system, CDMO, LPPS, Investment, FDA, Saudi Standards, Metrology and Quality Organization, SPPS, HPLC, Fine chemical

AmbioPharm , a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production.

Key Points: 
  • AmbioPharm , a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production.
  • A reliable peptide CDMO with manufacturing facilities both in China and the USA, AmbioPharm is ready to meet the needs of a global market.
  • A hydrogenation facility for Liquid Phase Peptide Synthesis (LPPS) was also recently completed and fully qualified.
  • Working in close collaboration with our Shanghai campus, we offer end-to-end peptide manufacturing for clinical and commercial applications.

AmbioPharm Provides an Update on Shanghai Campus Expansion and Resumption of Customer Visits

Retrieved on: 
Tuesday, April 25, 2023
Biotechnology, Health, Science, Pharmaceutical, Research, COVID, Hydrogenation, API, Growth, LPPS, Multimedia, SPPS, HPLC, Fine chemical

The latest addition to the AmbioPharm Shanghai campus1,2 brings a total of approximately 380,550 square feet of manufacturing and administrative space.

Key Points: 
  • The latest addition to the AmbioPharm Shanghai campus1,2 brings a total of approximately 380,550 square feet of manufacturing and administrative space.
  • The ongoing expansion to the Shanghai campus includes reactors as large as 5,000 liters and additional purification suites, including a new 60cm HPLC column.
  • Furthermore, we have resumed in-person site visits in our Shanghai campus.
  • “Now that the COVID restrictions have been eased in China in late 2022, we welcome onsite customer visits and audits of our Shanghai campus,” says Brant Zell, Sr. VP of Quality.

T3P - A Versatile Peptide Coupling and Water Removal Reagent, Offering Several Process Advantages, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, December 1, 2022
LPPS, Beckmann rearrangement, N,N'-Dicyclohexylcarbodiimide, SPPS, DCC, Food, Fine chemical, T3P, Lossen rearrangement

TORONTO, Dec. 1, 2022 /PRNewswire-PRWeb/ -- T3P or propanephosphonic acid anhydride, is an exceptional green reagent for use in condensation reactions and has attracted the attention of almost all innovative pharmaceutical companies worldwide during the past decade. Many applications for T3P use are in amidations and peptide coupling reactions — both LPPS (liquid-phase peptide synthesis) and SPPS (solid-phase peptide synthesis). However, the reagent may readily be used for various other functional group transformation reactions including nitrile formation from carboxamides, alcohol oxidation (Swern-type oxidation), ester formation, Lossen rearrangement, Beckmann rearrangement and heterocycle formation.

Key Points: 
  • In this free webinar, learn about a versatile peptide coupling and water removal reagent that offers several process advantages.
  • Many applications for T3P use are in amidations and peptide coupling reactions both LPPS (liquid-phase peptide synthesis) and SPPS (solid-phase peptide synthesis).
  • Register for this webinar to learn about a versatile peptide coupling & water removal reagent that offers several process advantages.
  • For more information, or to register for this event, visit T3P A Versatile Peptide Coupling and Water Removal Reagent, Offering Several Process Advantages .

Global Peptide Therapeutics Marketplace 2021-2026: Key Applications, Drug Types, Types of Manufacturing, Synthesis Technologies, Regions & Players - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 14, 2021
Health, Pharmaceutical, Cancer, Antibody, Growth, Radiation, Death, Protein, Solubility, Patient, Peptide, Technology, Research, LPPS, Degenerative disease, Conditional sentence, Therapy, Swelling, Drug resistance, Fine chemical

Since there is an increasing number of cancer patients, it is eventually increasing the prescription of peptide therapeutics to treat cancer.

Key Points: 
  • Since there is an increasing number of cancer patients, it is eventually increasing the prescription of peptide therapeutics to treat cancer.
  • As per the market by drug type, the innovative peptides segment has a significant share in the peptide therapeutics market.
  • Further, the market is based on the type of manufacturing; in this segmentation, the in-house manufacturing segment has a major contribution to the peptide therapeutics market share.
  • According to the synthesis technology, the liquid phase peptide synthesis (LPPS) segment has dominated the peptide therapeutics market share.

Global Peptide Therapeutics Market (2021 to 2025) - by Type, Synthesis Technology, Manufacturing Type, Application and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, August 13, 2021
Pharmaceutical, Health, Oncology, Neonatology, LPPS, Diabetes, Conditional sentence, SPPS, Gastroenterology, Research, Motor vehicle, Analgesic, Patient, Investment, Technology, Incidence, Cancer, Peptide, API, Adoption, Lists of diseases, Therapy, Fine chemical

The global peptide therapeutics market can be segmented on the basis of type, synthesis technology, manufacturing type and application.

Key Points: 
  • The global peptide therapeutics market can be segmented on the basis of type, synthesis technology, manufacturing type and application.
  • According to synthesis technology, the market can be categorized into Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS) and Hybrid Technology.
  • In terms of application, the global peptide therapeutics market can be split into chemotherapy, gastroenterology, analgesia, diabetes, paediatric & neonatology and other applications.
  • The report provides a comprehensive analysis of the global peptide therapeutics market segmented on the basis of type, synthesis technology, manufacturing type and application region.